Skip to main content

Advertisement

Table 1 Clinical characteristics of patients with coronary artery disease and diabetes mellitus type 2

From: Disturbed angiogenic activity of adipose-derived stromal cells obtained from patients with coronary artery disease and diabetes mellitus type 2

Clinical characteristics Groups of patients p
Control CAD CAD + DM2
Number of patients 19 32 28 -
Age, years 56,7 ± 12,3 62,3 ± 8,6 61,0 ± 8,2 NS
Gender, male, n (%) 5 (26,3%) 29 (90,6%) 17 (60,7%) <0,05
Functional class of stable angina, n (%) - II FC-8 (25%), II FC-5 (18%), NS
III FC - 13 (41%), III FC-9 (32%),
IV FC – 11 (34%) IV FC-14 (50%)
MI in past history, n (%) - 20 (63%) 18 (64%) NS
The score of coronary artery atherosclerosis, n (%) - 2CA-6 (18,8%) 2CA-5 (17,9%) NS
3CA-26 (81,3%) 3CA-23 (82,1%)
Ejection fraction (%) 57,8 ± 1,8 55,0 ± 9,8 58,0 ± 9,2 NS
Arterial hypertension, n (%) 3 (15,8%) 27 (84%) 24 (86%) <0,05
Obesity, n (%) 12 (63%) 20 (63%) 19 (68%) NS
BMI, kg/m2 28,6 ± 3,7 30,6 ± 0,8 28,14 ± 1,07 NS
Total protein, g/l 68,7 ± 1,9 69,4 ± 1,6 72,1 ± 3,2 NS
Glucose, mmol/l 5,46 ± 2,2 5,4 ± 3,2 10,1 ± 4,1 <0,05
Triglyceride, mmol/l 1,7 ± 1,3 2,1 ± 1,1 1,9 ± 0,9 NS
Cholesterol, mmol/l 4,4 ± 0,4 4,5 ± 0,4 4,9 ± 0,9 NS
Urea, mmol/l 5,9 ± 0,8 6,2 ± 0,5 9,02 ± 1,5 NS
Creatinine, ummol/l 68,8 ± 9,5 66,6 ± 7,5 139,8 ± 23,2 <0,01
Medical treatment before CABG
β-blockers, n (%) - 27 (84%) 23 (82%) NS
Antiplatelet agents, n (%) - 32 (100%) 28 (100%) NS
Statins, n (%) - 28 (88%) 25 (89%) NS
ACE inhibitors, n (%) - 20 (63%) 18 (64%) NS
Calcium antagonists, n (%) - 13 (41%) 12 (43%) NS
Diuretics, n (%) - 23 (72%) 21 (75%) NS
Nitrates, n (%) - 27 (84%) 23 (82%) NS
  1. FC – Functional class, BMI – Body mass index, CABG – Coronary artery bypass grafting, p – p-value for multiple comparison of patient’s groups, NS – Non-significant.